Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Hormones and iron deficiency are linked to female pattern hair loss, and hair thinning patterns are similar across different types of this condition.

A manual blood cell counter was effectively used to count hair follicles during surgery, being user-friendly and cost-effective but limited by a three-digit display.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Tofacitinib may help treat severe hair loss, but more research is needed.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Obese women with PCOS are more likely to have fatty liver disease.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Fungal infections in lab animals can interfere with research.

In situ DNA labeling in hair can help predict forensic DNA analysis success.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Intense exercise at night can delay the body's internal clock gene expression by 2 to 4 hours.

Caffeine-based liquid 0.2% is as effective as minoxidil 5% for treating male hair loss.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Some off-label treatments increase hair density, but long-term safety unknown.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Most off-label drug prescriptions in Saudi Arabia are for adults with depression and diabetes.

The conclusion cannot be provided because the document content is not available.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Polyethylene alanine caused hair loss in young lab animals but not in adults, with hair regrowth occurring within 20 days.

Vitamin supplements may not improve hair thickness or density in patients with non-scarring hair loss.